BindingDB logo
myBDB logout

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28336141 53 The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.EBI Glaxosmithkline
22942319 16 Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048.EBI Chdi Management/Chdi Foundation
25590515 139 Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.EBI Evotec (Uk)
22525315 1 Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata.EBI Griffith University
8126705 8 Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.EBI Universit£
9873646 41 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.EBI Pharmacia & Upjohn
 4 Synthesis and activity of enantiopure (S) (m-nitrobenzoyl) alanine, potent kynurenine-3-hydroxylase inhibitorEBI TBA
10633043 27 Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents.EBI Glaxo Wellcome Research And Development
9435907 23 Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.EBI F. Hoffmann-La Roche